Limited Use Note(s)

Government of Ontario Logo
FILGRASTIM480mcg/1.6mL 1.6mL Vial
Reason For Use CodeClinical Criteria
682For the treatment of low white blood cell count in patients who meet the following criteria: - Patients who become pregnant during the transition period of July 31, 2024, to January 31, 2025.
LU Authorization Period: 12 months from date of authorization.
683For the treatment of low white blood cell count in patients who meet the following criteria: - Patients who require palliative care during the transition period of July 31, 2024, to January 31, 2025.
LU Authorization Period: 12 months from date of authorization.